Collecting rare diseases

F1000Res. 2014 Oct 31;3:260. doi: 10.12688/f1000research.5577.1. eCollection 2014.

Abstract

This editorial introduces the F1000Research rare disease collection. It is common knowledge that for new treatments to be successful there has to be a partnership between the many interested parties such as the patient, advocate, disease foundations, the academic scientists, venture funding organizations, biotech companies, pharmaceutical companies, NIH, and the FDA. Our intention is to provide a forum for discussion and dissemination of any rare disease related topics that will advance scientific understanding and progress to treatments.

Grant support

The author(s) declared that no grants were involved in supporting this work.